Source: Virtual Congress 2021 – Advances in asthma treatment



Rating:

Share or cite this content

Citations should be made in the following way:
J. Leroux (Strasbourg, France), N. Khayath (Strasbourg, France), C. Matau (Strasbourg, France), D. Ochea (Strasbourg, France), F. Lefebvre (Strasbourg, France), A. Molard (Strasbourg, France), F. De Blay (Strasbourg, France). Bronchial Thermosplaty and severe asthma with frequent severe exacerbations : a controlled study.. 3524

Member's Comments

No comment yet.

Related content which might interest you: Bronchial asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study Source: Eur Respir J 2004; 24: Suppl. 48, 260s Year: 2004 Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Difficult-to-treat and severe asthma Source: Breathe 2014; 10: 91-94 Year: 2014 Aspiration and severe exacerbations in COPD: a prospective study Source: ERJ Open Res, 7 (1) 00735-2020; 10.1183/23120541.00735-2020 Year: 2021 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Asthma exacerbations in relation to severe asthma Source: Eur Respir Mon 2011; 51: 120-129 Year: 2011 Clinical response of severe asthma patients following Bronchial Thermoplasty. Source: International Congress 2017 – To freeze or heat? Year: 2017 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001